comparemela.com

Latest Breaking News On - Investigational medicinal product - Page 9 : comparemela.com

Clinical trials for medicines: manage your authorisation, report safety issues

Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.

United kingdomResearch ethics committeeDevelopment safety updateEuropean commissionRegulatory agencyHealth research authorityNational competent authoritiesHealth canadaResearch application systemHealth research authority annual progressCombined waysClinical trialsInvestigational medicinal productsIntegrated research application systemClinical trial authorisationSubstantial amendment

MGC Pharmaceuticals Ltd advances phase 3 clinical trial of CimetrA for the treatment of COVID-19

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) is currently undertaking a phase 3 clinical trial of CimetrA in Israel as an investigational medicinal.

United statesRoby zomerBrent yessinGraft polymer ip ltdGraft polymerGraftbio self nanoemulsifying drug deliveryInvestigational medicinal productIsrael julyClinical trialsSouth americaEast asiaEmergency useEastern european

Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: AMC USA Places a US$3M Purchase Order for CimetrA

Investegate announcements from MGC Pharmaceuticals, AMC USA Places a US$3M Purchase Order for CimetrA

United statesUnited kingdomUniversity of south floridaCity ofFort lauderdaleHoly cross hospitalJames cusackBrett scottBobby oneillCharles vivian tim pearsonPharma cannepilConrad burnsDavid limBrent yessinTurner popeRoby zomer

endpoint and Berlinger Collaborate to Provide Complete Visibility of the Historical Temperature Journey of an IMP

/PRNewswire/ endpoint Clinical, the leader in global interactive response technology (IRT®) for clinical trials, and Berlinger & Co. AG, specializing in the.

United statesSan franciscoBarbara hoefelmayrJeff rubesinMonica holtHarald van weerenMarketing communicationsBerlinger coInvestigational medicinal productSegment manager clinical trialsSenior directorProduct strategyDoping control equipmentCommunications managerEndpoint clinical

endpoint and Berlinger Collaborate to Provide Complete Visibility of the Historical Temperature Journey of an IMP

Fully integrated solution: Turn a 25-day manual temperature-monitoring data evaluation into instant decision making

United statesSan franciscoJeff rubesinMonica holtHarald van weerenMarketing communicationsBerlinger coInvestigational medicinal productSegment manager clinical trialsSenior directorProduct strategyDoping control equipmentMarketing communications managerHoefelmayr marketing manager

vimarsana © 2020. All Rights Reserved.